Credit Suisse’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$13.2M Sell
847,520
-5,996
-0.7% -$93.7K 0.01% 790
2023
Q4
$12.7M Buy
853,516
+28,557
+3% +$426K 0.01% 810
2023
Q3
$13.3M Buy
824,959
+7,223
+0.9% +$117K 0.01% 778
2023
Q2
$33.9M Sell
817,736
-59,952
-7% -$2.49M 0.03% 497
2023
Q1
$52.8M Sell
877,688
-82,358
-9% -$4.95M 0.05% 371
2022
Q4
$70.4M Sell
960,046
-119,050
-11% -$8.73M 0.07% 278
2022
Q3
$82M Sell
1,079,096
-1,140
-0.1% -$86.6K 0.09% 225
2022
Q2
$75.1M Sell
1,080,236
-282,747
-21% -$19.7M 0.08% 261
2022
Q1
$113M Buy
1,362,983
+1,660
+0.1% +$138K 0.1% 215
2021
Q4
$102M Sell
1,361,323
-23,028
-2% -$1.73M 0.05% 246
2021
Q3
$161M Buy
1,384,351
+114,847
+9% +$13.3M 0.09% 163
2021
Q2
$282M Sell
1,269,504
-363,347
-22% -$80.6M 0.15% 95
2021
Q1
$216M Buy
1,632,851
+178,392
+12% +$23.6M 0.11% 141
2020
Q4
$252M Sell
1,454,459
-192,511
-12% -$33.3M 0.12% 104
2020
Q3
$183M Sell
1,646,970
-550,890
-25% -$61.3M 0.11% 122
2020
Q2
$130M Buy
2,197,860
+913,568
+71% +$54.2M 0.09% 171
2020
Q1
$86.5M Buy
1,284,292
+323,594
+34% +$21.8M 0.07% 215
2019
Q4
$81M Sell
960,698
-37,673
-4% -$3.17M 0.06% 277
2019
Q3
$74.7M Sell
998,371
-187,216
-16% -$14M 0.06% 242
2019
Q2
$75M Buy
1,185,587
+3,777
+0.3% +$239K 0.07% 235
2019
Q1
$56.9M Sell
1,181,810
-305,761
-21% -$14.7M 0.05% 292
2018
Q4
$49.8M Buy
1,487,571
+541,917
+57% +$18.1M 0.05% 318
2018
Q3
$49.6M Buy
945,654
+440,543
+87% +$23.1M 0.04% 361
2018
Q2
$15.8M Buy
505,111
+415,809
+466% +$13M 0.02% 794
2018
Q1
$1.95M Buy
89,302
+38,255
+75% +$834K ﹤0.01% 2084
2017
Q4
$1.03M Sell
51,047
-15,664
-23% -$317K ﹤0.01% 2510
2017
Q3
$1.32M Buy
66,711
+30,017
+82% +$596K ﹤0.01% 2456
2017
Q2
$635K Buy
36,694
+12,280
+50% +$213K ﹤0.01% 2616
2017
Q1
$197K Sell
24,414
-15,848
-39% -$128K ﹤0.01% 3252
2016
Q4
$315K Buy
40,262
+10,354
+35% +$81K ﹤0.01% 3281
2016
Q3
$255K Sell
29,908
-1,767
-6% -$15.1K ﹤0.01% 3380
2016
Q2
$370K Buy
+31,675
New +$370K ﹤0.01% 3286